Champions Oncology Inc
Healthcare · EUR · F
Price
€4.876
Cap
€83.60M
Earnings
—
30d Trend
+2.1%
48% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 54×Macro 0.99 (−1%)=53
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder — quality business with growth runway
BRAIN47'S ASSESSMENT
I rate Champions Oncology Inc at 53/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 73/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-0.7%
3 MONTHS
-1.5%
12 MONTHS
-1.8%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder — quality business with growth runway. Quality (73) and Fundamentals (71) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 48%. I classify this as a speculative position — elevated volatility at 48% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.